Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Tan FionaChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $920K 8,000 sh | Oct 22, 2026 |
| 22 | Saba Capital Management, L.P.10% Owner | Open-market purchase | BUY | $26K 2,462 sh | Oct 22, 2026 traded Oct 21, 2026 |
| 21 | Mathews Darrell Lee Jr.Executive Vice President | Open-market sale | SELL | $7,859 136 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 20 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Oct 22, 2026 traded Oct 1, 2026 |
| 20 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Oct 22, 2026 traded Oct 1, 2026 |
| 20 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Oct 22, 2026 traded Oct 1, 2026 |
| 20 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Oct 22, 2026 traded Oct 9, 2026 |
| 19 | Neagle MatthewChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $563K 31.3K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 18 | Kiernan MichaelChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $127K 50.0K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 18 | Hyman JonathanChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $12.92M 285.0K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $1.29M 7,420 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Chang Fred FachingDirector, 10% Owner | Open-market sale | SELL | $38K 3,582 sh | Oct 22, 2026 traded Oct 21, 2026 |
| 17 | Narayanadas VivekGeneral Counsel & Secretary | Open-market sale · 10b5-1 plan | SELL | $27K 1,021 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $1.08M 6,190 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Chang Fred FachingDirector, 10% Owner | Open-market sale | SELL | $38K 3,582 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Kneppers Chris JDirector | Open-market sale | SELL | $13K 125.5K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 15 | Dai KunDirector, Chief Executive Officer | Open-market purchase · 10b5-1 plan | BUY | $3,755 4,002 sh | Oct 22, 2026 traded Oct 21, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $261K 1,523 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $579K 3,300 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $637K 3,690 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 14 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $6.52M 185.9K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 13 | Wirth James FPresident & CEO, 10% Owner, Chairman | Open-market sale · 10b5-1 plan | SELL | $2.01B 43.1K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 12 | King Ryan ADirector, Co-Founder | Open-market sale · 10b5-1 plan | SELL | $351K 11.3K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $98K 577 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $67K 400 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $67K 400 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $98K 600 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $135K 800 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $176K 1,000 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $113K 700 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $66K 400 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $82K 500 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 10 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.25M 7,369 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 10 | Hyman JonathanChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $300K 10.0K sh | Oct 22, 2026 traded Oct 15, 2026 |
| 8 | Kuykendall AnneSVP and Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $41K 738 sh | Oct 22, 2026 traded Oct 22, 2026 |
| 7 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $268K 1,589 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 7 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $501K 14.1K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 7 | Denier Anthony MichaelDirector, President | Open-market sale · 10b5-1 plan | SELL | $328K 53.8K sh | Oct 22, 2026 traded Oct 21, 2026 |
| 7 | O'Toole Brian EDirector, CEO and President | Open-market sale · 10b5-1 plan | SELL | $337K 20.0K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 6 | Bentley Sheldon RichardFounder | Open-market sale · 10b5-1 plan | SELL | $3,285 1,500 sh | Oct 22, 2026 traded Oct 21, 2026 |